\-\ Texto\\:\\ \ \(0\)\
\-\ obese\\ female\\ in\\ no\\ apparent\\ distress\\ with\\ facial\\ and\\ bilateral\\ upper\\ extremity\\ edema\\.\\ \\ wbc\\ \\=\\ 2\\.9\\ x103\\ per\\ \\&\\#956\\;l\\.\ \(0\)\
\-\ this\\ patient\\ was\\ treated\\ with\\ local\\ thrombolysis\\ via\\ catheter\\ infusion\\ of\\ tissue\\ plasminogen\\ activator\\ \\(tpa\\)\\ as\\ well\\ as\\ multiple\\ percutaneous\\ transluminal\\ angioplasties\\ \\(pta\\)\\ over\\ the\\ course\\ of\\ 3\\ days\\.\\ \\ ultimately\\ endovascular\\ mechanical\\ thrombectomy\\ in\\ combination\\ with\\ pta\\ yielded\\ the\\ final\\ result\\.\ \(0\)\
\-\ frontal\\ cxr\\ \\â\\€\\“\\ central\\ venous\\ catheter\\ placement\\ with\\ tip\\ in\\ the\\ region\\ of\\ the\\ svc\\.\\ \\ absent\\ right\\ breast\\ shadow\\ consistent\\ with\\ past\\ mastectomy\\.\\ \\ widened\\ superior\\ mediastinum\\,\\ right\\ greater\\ than\\ left\\,\\ in\\ the\\ region\\ of\\ the\\ azygos\\ vein\\.\\ \\ \ \(0\)\
\-\ axial\\ ct\\ w\\/contrast\\ at\\ the\\ level\\ of\\ the\\ aortic\\ arch\\ \\â\\€\\“\\ homogeneous\\ filling\\ defect\\ in\\ the\\ svc\\.\ \(0\)\
\-\ venography\\ \\(initial\\)\\ \\â\\€\\“\\ this\\ demonstrates\\ occlusion\\ of\\ the\\ right\\ brachiocephalic\\ vein\\ with\\ complete\\ absence\\ of\\ opacification\\ inferior\\ to\\ obstruction\\ as\\ well\\ as\\ opacification\\ of\\ a\\ dilated\\ azygos\\ vein\\ collateral\\.\ \(0\)\
\-\ venography\\ \\(final\\)\\ \\â\\€\\“\\ this\\ demonstrates\\ reconstitution\\ of\\ flow\\ through\\ the\\ right\\ brachiocephalic\\ vein\\ into\\ the\\ svc\\ without\\ backfilling\\ of\\ collateral\\ vessels\\.\ \(0\)\
\-\ svc\\ syndrome\\ secondary\\ to\\ central\\ catheter\\-related\\ venous\\ thrombosis\\.\ \(0\)\
\-\ given\\ radiographic\\ findings\\,\\ differential\\ considerations\\ would\\ include\\ lymphoma\\,\\ infectious\\ process\\,\\ non\\-infectious\\ granulomatous\\ disease\\ \\(sarcoid\\)\\,\\ and\\ venous\\ thrombosis\\.\\ \\ ct\\ confirms\\ thrombosis\\ in\\ the\\ svc\\ and\\ venography\\ confirms\\ consequent\\ svc\\ syndrome\\.\ \(0\)\
\-\ this\\ 43\\ yo\\ woman\\ presented\\ with\\ a\\ 5\\-day\\ history\\ of\\ bilateral\\ facial\\,\\ neck\\,\\ and\\ upper\\ extremity\\ swelling\\,\\ as\\ well\\ as\\ episodes\\ of\\ dizziness\\ and\\ syncope\\.\ \(0\)\
\-\ this\\ patient\\ was\\ diagnosed\\ with\\ poorly\\ differentiated\\ infiltrating\\ ductal\\ carcinoma\\ and\\ subsequently\\ treated\\ with\\ a\\ right\\ modified\\ radical\\ mastectomy\\ approximately\\ 4\\ months\\ prior\\ to\\ current\\ admission\\.\\ \\ a\\ right\\-sided\\ indwelling\\ central\\ catheter\\ had\\ been\\ in\\ place\\ for\\ approximately\\ 3\\.5\\ months\\ and\\ the\\ patient\\ was\\ status\\-post\\ 6\\ cycles\\ of\\ doxorubicin\\ and\\ cyclophosphamide\\ \\(ac\\)\\ chemotherapy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ svc\\:\\ 0\\.39412336695520955\ \(0\)\
\-\ venography\\:\\ 0\\.2352520251843143\ \(0\)\
\-\ catheter\\:\\ 0\\.2087741942989707\ \(0\)\
\-\ vein\\:\\ 0\\.1683463954612209\ \(0\)\
\-\ the\\:\\ 0\\.1640223250795628\ \(0\)\
\-\ pta\\:\\ 0\\.1509124062632367\ \(0\)\
\-\ azygos\\:\\ 0\\.1509124062632367\ \(0\)\
\-\ of\\:\\ 0\\.14937485985969537\ \(0\)\
\-\ brachiocephalic\\:\\ 0\\.14773903140660483\ \(0\)\
\-\ thrombosis\\:\\ 0\\.14361586050445949\ \(0\)\
\-\ as\\:\\ 0\\.14152872887231546\ \(0\)\
\-\ venous\\:\\ 0\\.12576092820438473\ \(0\)\
\-\ mastectomy\\:\\ 0\\.12463838918509683\ \(0\)\
\-\ central\\:\\ 0\\.11762887020843488\ \(0\)\
\-\ right\\:\\ 0\\.11679981135462494\ \(0\)\
\-\ final\\:\\ 0\\.11520358304154138\ \(0\)\
\-\ confirms\\:\\ 0\\.11346286876502042\ \(0\)\
\-\ opacification\\:\\ 0\\.11291387122017786\ \(0\)\
\-\ collateral\\:\\ 0\\.11237913497682647\ \(0\)\
\-\ with\\:\\ 0\\.10347515397890825\ \(0\)\
\-\ in\\:\\ 0\\.10224566818174032\ \(0\)\
\-\ this\\:\\ 0\\.10087860696242817\ \(0\)\
\-\ and\\:\\ 0\\.0970628014101989\ \(0\)\
\-\ facial\\:\\ 0\\.09683082037073602\ \(0\)\
\-\ infectious\\:\\ 0\\.09448895858385437\ \(0\)\
\-\ x103\\:\\ 0\\.09389895166555942\ \(0\)\
\-\ plasminogen\\:\\ 0\\.09389895166555942\ \(0\)\
\-\ activator\\:\\ 0\\.09389895166555942\ \(0\)\
\-\ angioplasties\\:\\ 0\\.09389895166555942\ \(0\)\
\-\ 956\\:\\ 0\\.08972546121857002\ \(0\)\
\-\ transluminal\\:\\ 0\\.08676432262208358\ \(0\)\
\-\ backfilling\\:\\ 0\\.08676432262208358\ \(0\)\
\-\ consequent\\:\\ 0\\.08676432262208358\ \(0\)\
\-\ well\\:\\ 0\\.08529108062392218\ \(0\)\
\-\ extremity\\:\\ 0\\.08457951726058281\ \(0\)\
\-\ tpa\\:\\ 0\\.08100414474677825\ \(0\)\
\-\ indwelling\\:\\ 0\\.07841734172810477\ \(0\)\
\-\ reconstitution\\:\\ 0\\.07635181940878699\ \(0\)\
\-\ approximately\\:\\ 0\\.07492959747861017\ \(0\)\
\-\ thrombectomy\\:\\ 0\\.0746323160223543\ \(0\)\
\-\ cycles\\:\\ 0\\.07315936559592413\ \(0\)\
\-\ doxorubicin\\:\\ 0\\.07315936559592413\ \(0\)\
\-\ cyclophosphamide\\:\\ 0\\.07315936559592413\ \(0\)\
\-\ treated\\:\\ 0\\.0731276680220425\ \(0\)\
\-\ thrombolysis\\:\\ 0\\.07128271268462893\ \(0\)\
\-\ yielded\\:\\ 0\\.07128271268462893\ \(0\)\
\-\ ac\\:\\ 0\\.07128271268462893\ \(0\)\
\-\ syndrome\\:\\ 0\\.07079466241420868\ \(0\)\
\-\ region\\:\\ 0\\.0702419798809236\ \(0\)\
\-\ syncope\\:\\ 0\\.06921719036531117\ \(0\)\
\-\ months\\:\\ 0\\.06835440435819053\ \(0\)\
\-\ modified\\:\\ 0\\.06832157408814252\ \(0\)\
\-\ infusion\\:\\ 0\\.06749768697887848\ \(0\)\
\-\ endovascular\\:\\ 0\\.06504369991832175\ \(0\)\
\-\ radical\\:\\ 0\\.06504369991832175\ \(0\)\
\-\ bilateral\\:\\ 0\\.06311180969099946\ \(0\)\
\-\ upper\\:\\ 0\\.06275336439827767\ \(0\)\
\-\ widened\\:\\ 0\\.062319194592548414\ \(0\)\
\-\ ultimately\\:\\ 0\\.06140364976328892\ \(0\)\
\-\ was\\:\\ 0\\.06138885459875701\ \(0\)\
\-\ obese\\:\\ 0\\.06076676042026767\ \(0\)\
\-\ considerations\\:\\ 0\\.06076676042026767\ \(0\)\
\-\ shadow\\:\\ 0\\.0599745931941637\ \(0\)\
\-\ demonstrates\\:\\ 0\\.05899611070188494\ \(0\)\
\-\ mechanical\\:\\ 0\\.058225806448180276\ \(0\)\
\-\ infiltrating\\:\\ 0\\.05760179152077069\ \(0\)\
\-\ dizziness\\:\\ 0\\.05730342008065654\ \(0\)\
\-\ patient\\:\\ 0\\.057291665413647774\ \(0\)\
\-\ percutaneous\\:\\ 0\\.05659326997327825\ \(0\)\
\-\ differentiated\\:\\ 0\\.0560584434993871\ \(0\)\
\-\ tip\\:\\ 0\\.055184565549072584\ \(0\)\
\-\ sarcoid\\:\\ 0\\.055065568918079226\ \(0\)\
\-\ 43\\:\\ 0\\.0549479322783595\ \(0\)\
\-\ combination\\:\\ 0\\.0544903861104369\ \(0\)\
\-\ occlusion\\:\\ 0\\.053945650860757866\ \(0\)\
\-\ episodes\\:\\ 0\\.05363213137679184\ \(0\)\
\-\ poorly\\:\\ 0\\.05303236403171354\ \(0\)\
\-\ place\\:\\ 0\\.05293571455222415\ \(0\)\
\-\ mediastinum\\:\\ 0\\.05255794393552079\ \(0\)\
\-\ granulomatous\\:\\ 0\\.052193548574742676\ \(0\)\
\-\ homogeneous\\:\\ 0\\.05184161364546534\ \(0\)\
\-\ ductal\\:\\ 0\\.05167005810853873\ \(0\)\
\-\ current\\:\\ 0\\.051417969738916595\ \(0\)\
\-\ local\\:\\ 0\\.050543126614993654\ \(0\)\
\-\ subsequently\\:\\ 0\\.050095530272823686\ \(0\)\
\-\ arch\\:\\ 0\\.04980759278589858\ \(0\)\
\-\ apparent\\:\\ 0\\.04912113220322238\ \(0\)\
\-\ admission\\:\\ 0\\.04898916765285164\ \(0\)\
\-\ per\\:\\ 0\\.048730208235131536\ \(0\)\
\-\ absent\\:\\ 0\\.04817032494160064\ \(0\)\
\-\ via\\:\\ 0\\.04799026622869305\ \(0\)\
\-\ distress\\:\\ 0\\.04729996780334016\ \(0\)\
\-\ cxr\\:\\ 0\\.04697143691766038\ \(0\)\
\-\ absence\\:\\ 0\\.046811021817282035\ \(0\)\
\-\ placement\\:\\ 0\\.04584929680972008\ \(0\)\
\-\ vessels\\:\\ 0\\.045563359146764675\ \(0\)\
\-\ filling\\:\\ 0\\.045469784921041395\ \(0\)\
\-\ aortic\\:\\ 0\\.04537705371781615\ \(0\)\
\-\ ct\\:\\ 0\\.044707124594372975\ \(0\)\
\-\ process\\:\\ 0\\.04403727892361994\ \(0\)\
\-\ to\\:\\ 0\\.04403631874756186\ \(0\)\
\-\ result\\:\\ 0\\.04395654836122862\ \(0\)\
\-\ radiographic\\:\\ 0\\.04356212869130774\ \(0\)\
\-\ course\\:\\ 0\\.04337044542489158\ \(0\)\
\-\ greater\\:\\ 0\\.04325712581494601\ \(0\)\
\-\ defect\\:\\ 0\\.04307098884493777\ \(0\)\
\-\ breast\\:\\ 0\\.04263753137029262\ \(0\)\
\-\ diagnosed\\:\\ 0\\.04253196025058016\ \(0\)\
\-\ dilated\\:\\ 0\\.04205312535957832\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.04169192710829621\ \(0\)\
\-\ would\\:\\ 0\\.041563662595727684\ \(0\)\
\-\ wbc\\:\\ 0\\.041500124777062546\ \(0\)\
\-\ complete\\:\\ 0\\.041157509082409685\ \(0\)\
\-\ obstruction\\:\\ 0\\.04112692037062715\ \(0\)\
\-\ given\\:\\ 0\\.04039033337798283\ \(0\)\
\-\ inferior\\:\\ 0\\.03994515723190669\ \(0\)\
\-\ swelling\\:\\ 0\\.039518439383588164\ \(0\)\
\-\ initial\\:\\ 0\\.03938863824431833\ \(0\)\
\-\ flow\\:\\ 0\\.03910870990883321\ \(0\)\
\-\ past\\:\\ 0\\.03821937182273424\ \(0\)\
\-\ superior\\:\\ 0\\.03817342043418675\ \(0\)\
\-\ differential\\:\\ 0\\.038150521439337184\ \(0\)\
\-\ frontal\\:\\ 0\\.03779090079460878\ \(0\)\
\-\ days\\:\\ 0\\.03716948480521063\ \(0\)\
\-\ yo\\:\\ 0\\.036682146738227804\ \(0\)\
\-\ neck\\:\\ 0\\.035917929905867466\ \(0\)\
\-\ level\\:\\ 0\\.035467591506802426\ \(0\)\
\-\ carcinoma\\:\\ 0\\.0351209899404618\ \(0\)\
\-\ edema\\:\\ 0\\.03501924518511086\ \(0\)\
\-\ lymphoma\\:\\ 0\\.03496874748477734\ \(0\)\
\-\ through\\:\\ 0\\.034951969821829396\ \(0\)\
\-\ include\\:\\ 0\\.034935219461843796\ \(0\)\
\-\ secondary\\:\\ 0\\.034802188932398004\ \(0\)\
\-\ presented\\:\\ 0\\.03423958475755609\ \(0\)\
\-\ been\\:\\ 0\\.03420834620872421\ \(0\)\
\-\ axial\\:\\ 0\\.03391621489850086\ \(0\)\
\-\ than\\:\\ 0\\.03328417764157009\ \(0\)\
\-\ prior\\:\\ 0\\.0328514550572203\ \(0\)\
\-\ over\\:\\ 0\\.03264842887076337\ \(0\)\
\-\ consistent\\:\\ 0\\.03183692070940098\ \(0\)\
\-\ into\\:\\ 0\\.031212177196329113\ \(0\)\
\-\ without\\:\\ 0\\.03097024667165751\ \(0\)\
\-\ tissue\\:\\ 0\\.03080085567482538\ \(0\)\
\-\ woman\\:\\ 0\\.030579251982282545\ \(0\)\
\-\ had\\:\\ 0\\.029254247317238108\ \(0\)\
\-\ findings\\:\\ 0\\.028978480500768605\ \(0\)\
\-\ multiple\\:\\ 0\\.028719054860167136\ \(0\)\
\-\ female\\:\\ 0\\.028332962463326596\ \(0\)\
\-\ disease\\:\\ 0\\.024646703264717577\ \(0\)\
\-\ history\\:\\ 0\\.02243274033330154\ \(0\)\
\-\ at\\:\\ 0\\.022177607688774897\ \(0\)\
\-\ left\\:\\ 0\\.02002915571590163\ \(0\)\
\-\ no\\:\\ 0\\.019093629728456407\ \(0\)\
\-\ for\\:\\ 0\\.017796233492260394\ \(0\)\
